Formetco today announced that its LHG Innovation Center has surpassed $1 million raised for local Gwinnett County charities, marking a major milestone in the company's commitment to community ...

Lymphoma is a systemic cancer originating from lymphocytes, which are vital immune system cells that circulate rapidly throughout the body. Multicentric lymphoma accounts for up to 85 percent of all ...

Follicular lymphoma, a common and usually slow-growing type of non-Hodgkin lymphoma (NHL), has long been deemed incurable: Though the disease responds well to initial treatment, oncologists tell ...

The National Institute for Health and Care Excellence (NICE) has recommended epcoritamab (Tepkinly, AbbVie) as a treatment option for adults with relapsed or refractory follicular lymphoma after two ...

Many people learn they have lymphoma after they or their primary care provider (PCP) notices signs or symptoms. Some people develop symptoms quickly and are diagnosed within days or weeks. For others, ...

Corporate Social Responsibility (CSR), also known as corporate conscience, refers to a management idea that sees companies integrating social and environmental factors into their operations. CSR ...

Headlines have been challenging in 2025. Companies are under attack publicly and privately for policies viewed as “too progressive” or “woke.” The reality, however, is that most companies have ...

Hodgkin’s lymphoma is definitively diagnosed by the presence of Reed-Sternberg cells, whereas Non-Hodgkin’s lymphoma involves a wider range of lymphoid variations and is classified based on cell ...

MSK hematologist-oncologist Dr. Lia Palomba led a clinical trial that resulted in FDA approval of lisocabtagene maraleucel (Breyanzi®), a CAR T cell therapy, for marginal zone lymphoma. Marginal zone ...

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer ...